Addressing the Global Threat
The Faculty of Infectious Diseases effectively addresses infectious disease threats to species and economies world wide by integrating multidisciplinary research in animal, human, and ecosystem health, and by developing successful countermeasures, including vaccines, therapeutics, and diagnostics.
In the News
- Promoting Academic Partnerships: CDC-UGA Research Collaboration 1st Annual Research Forum
Search this compilation of forum participants’ information by keyword to find possible collaborators. To search the document, go to “Edit – Find” and type in a keyword. Press Enter after each hit to search the entire document. If your computer is equipped with Adobe Reader instead of the full Adobe Acrobat Professional you may not be able to search this document.
- Join Us
The Faculty of Infectious Diseases (FID) is composed of faculty, junior scientists, and industry partners who share a common goal to increase understanding of the basic biology of infectious agents, their interactions with human and animal hosts, their natural ecology, and the epidemiology of the diseases they cause, and to apply this knowledge to improving the detection, control and prevention of infectious diseases. September 1 is the fall deadline for submitting membership applications. more›
- Recent Expansion
Formation of the Faculty of Infectious Diseases, an initiative of the Office of the Vice President for Research, coincides with several recent research developments at UGA and in Georgia. more›
- New Faculty Recruitment
In order to expand significantly its research program in infectious diseases, UGA is recruiting to fill seven tenure track or tenured faculty positions. more›
- Seed Grant Awards
Three proposals were funded from the 21 submissions for the June 10th round of Faculty of Infectious Diseases Seed Grant applications. A total of $72,500 in funding from UGARF was awarded, plus an additional $10,000 in matching support generously provided by the Departments of Infectious Diseases and Biochemistry & Molecular Biology to the selected proposals. The funded applications were: - “Development of a High Throughput Screen for Combinatorial Trypanostatic and Transmission-Blocking Drugs for African Sleeping Sickness”; Stephen Hajduk (CBIO), PI; Torsten Ochsenreiter (BCMB) and Boris Striepen (CBIO), Co-PI’s
- “Mapping of Non-Classical T cell Responses to Influenza Virus Infection”; Mark Tompkins (IDIS), PI; Peter Jensen (University of Utah), collaborator
- “Use of the Guinea Pig Model to Identify Novel Mycobacterium tuberculosis Virulence Determinants”; Mary Hondalus (IDIS), PI and Christopher Sassetti (University of Massachusetts), collaborator
The next application deadline for Seed Grant proposals will be January 10, 2009.
